ATPW
INDV icon

Ashton Thomas Private Wealth’s Indivior Pharmaceuticals INDV Stock Holding History

Ashton Thomas Private Wealth’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Buy
+7,075
New +$234K 0.01% 1004

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ashton Thomas Private Wealth's INDV Position: Q1 2026 in Review

Ashton Thomas Private Wealth opened a new position in Indivior Pharmaceuticals (INDV) in Q1 2026: 7,075 shares worth $216K. The stake represents 0.01% of the portfolio and ranks #1004 among its holdings.

289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Ashton Thomas Private Wealth held 7,075 shares of Indivior Pharmaceuticals worth $216K as of Q1 2026.
  • Indivior Pharmaceuticals was a new Ashton Thomas Private Wealth position in Q1 2026.
  • Indivior Pharmaceuticals made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #1004 holding.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.